上谕集团(01633.HK)中期扭亏为盈至539万港元 在手合同4.73亿港元
格隆汇11月24日丨上谕集团(01633.HK)公布截至2021年9月30日止6个月的中期业绩,期内公司实现收入1.13亿港元,同比下降9.9%;公司拥有人应占期内盈利539.0万港元,上年同期为亏损1548.4万港元;每股基本盈利0.79港仙,不派中期股息。
公吿称,收益减少乃主要由于部分项目于该期间初完成,而新项目于该期间末获授并开始产生收入。
截止2021年9月30日,集团手头有9个项目,总合约金额约为4.73亿港元,其中4个项目预期将于下个财政年度完成。于该期间结束后,集团获授予一个地基工程项目,其合约金额约为950万港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.